21165 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Animal cells expressing foreign proteins
Methods for Generating Antigen-Specific Effector T Cells
#1202Cancer Vaccines and Therapeutic Methods
#1203Multipotent adult stem cells and methods for isolation
#1204Multipotent adult stem cells and methods for isolation
#1205ADENOVIRUS VACCINE UTILIZING IKK AS ADJUVANT
#1206Tumor vaccine
#1207Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same
#1208Method for producing dendritic cells
#1209METHOD FOR TREATING TUMOR USING IRRADIATED TUMOR CELL EXPRESSING HUMAN HEPATITIS B SURFACE ANTIGEN AND A PHARMACEUTICAL COMPOSITION COMPRISING THE TUMOR CELL
#1210Compositions and methods for treatment of neoplastic disease
#1211Anti-CD40 antibodies capable of blocking B-cell activation
#1212Cell Population Having Immunoregulatory Activity, Method for Isolation and Uses
#1213Immune Response Inducing Preparations
#1214HLA-A24-restricted cancer antigen peptides
#1215Increased T-cell tumor infiltration and eradication of metastases by mutant light
#1216Nucleic acids encoding B7-H4, a T cell immunoregulatory molecule
#1217Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
#1218Alteration of cell membrane with FasL
#1219Cytotoxic T lymphocyte
#1220Compositions comprising T cell receptors and methods of use thereof
#1221Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
#1222Expression of class II transactivator fusion proteins for control of tumor growth
#1223Modified toxins
#1224PD-1 ANTIBODIES IN COMBINATION WITH A CYTOKINE-SECRETING CELL AND METHODS OF USE THEREOF
#1225Methods for treating autoimmune diseases using B7-H4 polypeptides and fragments thereof
#1226B7-H3 and B7-H4, Novel Immunoregulatory Molecules
#1227MODIFIED DIPHTHERIA TOXINS
#1228ANTI-TUMOR VACCINES DELIVERED BY DENDRITIC CELLS DEVOID OF INTERLEUKIN-10
#1229SELECTION OF ANTIGEN-SPECIFIC T CELLS
#1230Cell therapy method for the treatment of tumors
#1231Strain-independent amplification of pathogens and vaccines thereto
#1232Antigen specific immunosuppression by dendritic cell therapy
#1233COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1234COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1235Cancer immunotherapy with semi-allogeneic cells
#1236Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#1237COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#1238Dendritic cells loaded with heat shocked melanoma cell bodies
#1239Antigen Transduced T Cells Used as a Delivery System for Antigens
#1240Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme
#1241Mapc generation of lung tissue
#1242Induced activation in dendritic cells
#1243Expression of HIV polypeptides and production of virus-like particles
#1244Universal GM-CSF expressing bystander human K562 cell line
#1245Methods of using B7-DC molecules to induce or enhance an immune response
#1246Use Of Mesenchymal Stem Cells Genetically Modified To Express A Suicide Gene For Treating A Cancer
#1247COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#1248METHOD FOR OBTAINING ANTIGEN-SPECIFIC TR1 REGULATORY LYMPHOCYTES
#1249Dendritic cell co-stimulatory molecules
#1250COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#1251COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#1252Compositions and methods for the therapy and diagnosis of prostate cancer
#1253COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1254COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1255COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1256COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF PROSTATE CANCER
#1257COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1258Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
#1259ANTIBODY CANCER IMMUNOTHERAPY
#1260COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1261COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1262COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1263COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER
#1264CELL COMPOSITION AND METHOD FOR TREATING CANCER
#1265B7-H3 and B7-H4, novel immunoregulatory molecules
#1266COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#1267COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF LUNG CANCER
#1268Tumor cell vaccines
#1269Nucleic acid cancer immunotherapy
#1270Multi-subtype FIV vaccines
#1271Compositions and methods for identifying antigens which elicit an immune response
#1272CANCER IMMUNOTHERAPY
#1273Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies
#1274Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies
#1275Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#1276POLYNUCLEOTIDES ENCODING ANTIGENIC HIV TYPE B POLYPEPTIDES, POLYPEPTIDES, AND USES THEREOF
#1277Vaccine
#1278Method for increasing tumor cell immunogenicity using heat shock protein
#1279Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1
#1280IMMUNE RESPONSES AGAINST HPV ANTIGENS ELICITED BY COMPOSITIONS COMPRISING AN HPV ANTIGEN AND A STRESS PROTEIN OR AN EXPRESSION VECTOR CAPABLE OF EXPRESSION OF THESE PROTEINS
#1281Adoptive immunotherapy with enhanced T lymphocyte survival
#1282Tumor Antigens and Uses Thereof
#1283Trojan horse immunotherapy
#1284Process for producing engineered targeted T cell and medicine
#1285Preloaded dendritic cell vaccines for treating cancer
#1286Compositions and methods for the therapy and diagnosis of breast cancer
#1287Compositions and Methods for Inducing Anti-Tumor Immunity
#1288Photochemical internalization for delivery of molecules into the cytosol
#1289Method for producing dendritic cells
#1290Method for Producing Gene Transferred Denritic Cells
#1291Vaccination Vectors Derived From Lymphotropic Human Herpes Viruses 6 and 7
#1292Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy
#1293Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cells
#1294Capsules Containing Transiently Transfected Cells, Method for Preparing Same and Uses Thereof
#1295Mrna Transfected Antigen Presenting Cells
#1296COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF FUNGAL DISEASES
#1297Therapeutic Compositions and Vaccines By Glycosyl-Phosphatidylinositol (Gpi)-Anchored Cytokines and Immunostimulatory Molecules
#1298Ras mutation and compositions and methods related thereto
#1299Modified vaccinia ankara expressing P53 in cancer immunotherapy
#1300Immunomodulating compositions and uses therefor
#1301Immune Modulation By Regulating Expression Of The "Minor" Gene In Immune Dendritic Cells
#1302Tumor-derived biological antigen presenting particles
#1303Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
#1304Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell
#1305Cell fusions and methods of making and using the same
#1306Method for the generation of antigen-specific lymphocytes
#1307Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor
#1308Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides
#1309Arthritis vaccines and methods
#1310HLA-A24-restricted cancer antigen peptides
#1311Mature dendritic cell compositions and methods for culturing same
#1312Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
#1313Immune effector cells pre-infected with oncolytic virus
#1314Composition comprising a nucleotide sequence encoding an ELA2 fusion protein and plasmacytoid dendritic cells
#1315Immunostimulatory nucleic acid molecules for activating dendritic cells
#1316ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)-GALACTOSYLTRANSFERASE
#1317Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyl transferase
#1318Nucleic acid encoding dendritic cell co-stimulatory molecules
#1319Compositions and methods for the therapy and diagnosis of breast cancer
#1320Cancer vaccine based on brother of regulator of imprinted sites molecule
#1321Modified t lymphocytes and uses therefor
#1322Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
#1323Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease
#1324T cell regulation
#1325Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
#1326Vaccinia virus nucleic acids, polypeptides and immunogenic compositions
#1327KDR peptides and vaccines comprising the same
#1328Helper virus-free herpesvirus amplicon particles and uses thereof
#1329Protective antigen of epstein barr virus
#1330Transfection of blood cells with mRNA for immune stimulation and gene therapy
#1331Genetically modified tumor cells as cancer vaccines
#1332Therapeutic anti-melanoma compounds
#1333Method of treating an autoimmune disease
#1334Induction of tumor and viral immunity using antigen presenting cell co-culture products and fusion products
#1335Allogeneic and xenogeneic transplantation
#1336Pharmaceutical compositions comprising an hiv envelope protein and cd4
#1337Dendritic cells loaded with heat shocked melanoma cell bodies
#1338Universal GM-CSF expressing bystander human K562 cell line
#1339Preparation and use of superior vaccines
#1340Herpes viruses for immune modulation
#1341Chorionic gonadotropin DNA vaccines and methods
#1342Tumor cells with increased immunogenicity and uses therfor
#1343Cancer-testis antigens
#1344Flagellin-based adjuvants and vaccines
#1345Compositions comprising a lung tumor antigen
#1346Compositions and methods for the therapy and diagnosis of breast cancer
#1347Human anti-cancer immunotherapy
#1348Cytotoxic T lymphocyte
#1349Adenovirus vectors for immunotherapy
#1350Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
#1351Method for making dendritic cell vaccines from embryonic stem cells
#1352Preloaded dendritic cell vaccines for treating cancer
#1353Cytokine-expressing cellular vaccines for treatment of prostate cancer
#1354Means of producing and utilising a population of disease specific cytotoxic t-lymphocytes
#1355Methods and compositions for the targeting of a systemic immune response to specific organs or tissues
#1356Method for tumor treatment using infusion of xenogeneic cells to induce hyperacute rejection and innocent bystander effect
#1357Multipotent adult stem cells
#1358Dual antigen specific T cells with trafficking ability
#1359Vectors and methods for long-term immune evasion to prolong transplant viability
#1360AAV vectors and methods
#1361Breast cancer cell lines and uses thereof
#1362Generation of antigen specific T suppressor cells for treatment of rejection
#1363Antitumor agents with the use of HSV
#1364Compositions and methods for modulating immune response
#1365Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
#1366Antigen specific T cell therapy
#1367Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer
#1368Adjuvant preparation for the induction of specific immunity
#1369Isolated peptide which binds to HLA-Cw*07 and uses thereof
#1370Sacromastigophoric therapeutic agent delivery system
#1371Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
#1372Nucleic acids encoding B7-H4, a T cell immunoregulatory molecule
#1373Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
#1374Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
#1375Cell targeting compositions and methods of using the same
#1376Prostate specific antigen oligoepitope peptide
#1377Compositions for eliciting immune response and methods for using same
#1378Multipotent adult stem cells and methods for isolation
#1379Semi-allogenic anti-tumour vaccine with HLA haplo-identical antigen-presenting cells
#1380Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
#1381In vitro induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
#1382Anti-CD40 antibodies capable of blocking B-cell activation
#1383Cell fusions and methods of making and using the same
#1384Targeting antigen-specific T cells for specific immunotherapy of autoimmune disease
#1385Pharmaceutical compositions containing angiogenic activators
#1386Use of bacterial 5' untranslated regions for nucleic acid expression
#1387Cells expressing anti-Fc receptor binding components
#1388Compositions and methods for treatment of neoplastic disease
#1389Cellular vaccines comprising adjuvants
#1390Methods of elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes
#1391Photochemical internalization for delivery of molecules into the cytosol
#1392Methods and reagents for decreasing clinical reaction to allergy
#1393Antigen presenting vesicles
#1394MHC class II antigen-presenting systems and methods for activating CD4T cells
#1395MHC class II antigen-presenting systems and methods for activating CD4T cells
#1396Method of treating or preventing disease characterized by cryptococcus neoformans infection
#1397Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
#1398Immune activation by double-stranded polynucleotides
#1399Allogenic vaccine that contains a costimulatory polypeptide-expresing tumor cell
#1400Increased T-cell tumor infiltration by mutant LIGHT
#1401Method for the generation of antigen-specific lymphocytes
#1402Modified antigen-presenting cells
#1403Cytokine-expressing cellular vaccine combinations
#1404Materials and methods for engineering cells and uses thereof in immuno-oncology
#1405Specific chimeric antigen receptor cells targeting human CLDN18A2, preparation method and application thereof
#1406Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#1407Materials and methods for engineering cells and uses thereof in immuno-oncology
#1408Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#1409Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#1410T-cell receptor-deficient T cell compositions
#1411T-cell receptor-deficient t cell compositions
#1412Recombinant NK cells expressing co-stimulatory molecules
#1413Use of car and bite technology coupled with an scFv from an antibody against human thymidine kinase 1 to specifically target tumors